Related Experiment Video
Updated: Jun 2, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Sarcomere protein gene mutations in patients with apical hypertrophic cardiomyopathy
Christiane Gruner1, Melanie Care, Katherine Siminovitch
1Division of Cardiology, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada. christiane.gruner@gmx.ch
Insights
Genetic testing revealed fewer positive genotypes in apical hypertrophic cardiomyopathy (HCM) patients compared to nonapical HCM. The most common genetic variants involved MYBPC3 and MYH7, suggesting further research is needed for apical HCM.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
Background:
- Apical hypertrophic cardiomyopathy (HCM) is characterized by left ventricular hypertrophy localized to the cardiac apex.
- Understanding the genetic underpinnings of apical HCM is crucial for diagnosis and treatment.
Purpose of the Study:
- To investigate and report genetic findings in a large cohort of unrelated patients with apical HCM.
- To compare genetic profiles of apical HCM with those of nonapical HCM.
Main Methods:
- Genetic testing was performed on 429 patients with HCM, including 61 diagnosed with apical HCM.
- A panel of 11 genes (8 sarcomere protein genes, GLA, PRKAG2, LAMP2) was utilized for genetic analysis.
Main Results:
- A positive genotype was identified in only 13% of apical HCM patients, significantly lower than the 40% in nonapical HCM (P<0.001).
- MYBPC3 and MYH7 were the most frequently implicated genes in genotype-positive apical HCM cases.
- No significant difference in maximal wall thickness or HCM-related event frequency was observed between genotype-positive and genotype-negative apical HCM patients.
Conclusions:
- Genetic mutations are less prevalent in apical HCM compared to nonapical HCM, primarily involving MYBPC3 and MYH7.
- The low rate of positive genotypes in apical HCM highlights the need for genome-wide association studies and gene expression profiling.
- The study found no significant genotype-phenotype correlation within the apical HCM cohort.
Background:
Apical hypertrophic cardiomyopathy (HCM) is a unique form of HCM with left ventricular hypertrophy confined to the cardiac apex. The purpose of our study was to report genetic findings in a large series of unrelated patients with apical HCM and compare them with a nonapical HCM cohort.
Methods And Results:
Overall, 429 patients with HCM underwent genetic testing. The panel included 8 sarcomere protein genes and 3 other genes (GLA, PRKAG2, and LAMP2). Sixty-one patients were diagnosed with apical HCM. A positive genotype was found in 8 patients with apical HCM. The genotype-positive and genotype-negative patients had similar maximal wall thicknesses (17.5 ± 3.5 mm versus 17.6 ± 3.3 mm, P = 0.71) and similar frequency of HCM-related events (2/8; 25% versus 13/53; 25%; P = 0.98). Thirteen percent with apical HCM and 40% with nonapical HCM had a positive genotype (P<0.001) most often involving the MYBPC3 and MYH7 genes.
Conclusions:
In apical HCM, a positive genotype was found less frequently than in nonapical HCM, and it was most often involving MYBPC3 and MYH7 genes. Only 13% of patients with apical HCM were found to be genotype positive, indicating that genome-wide association studies and gene expression profiling are needed for better understanding of the genetic background of the disease. There was no significant genotype-phenotype correlation in our cohort with apical HCM.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Actin Polymerization and Cell Motility
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate.
Cardiomyopathy V: Interprofessional Care
Satellite Stem Cells and Muscular Dystrophy

